Implantable Cardioverter-Defibrillator Use After Heart Transplantation A Gray Area for Primary Prevention

被引：4
|
作者：
Rubin, Geoffrey [1 ]
DeFilippis, Ersilia M. [1 ]
Farr, Maryjane A. [1 ]
Topkara, Veli K. [1 ]
Yarmohammadi, Hirad [1 ]
机构：
[1] Columbia Univ, Irving Med Ctr, Dept Med, Div Cardiol, 177 Ft Washington Ave,Room 637, New York, NY 10032 USA
来源：
JACC-CLINICAL ELECTROPHYSIOLOGY | 2021年 / 7卷 / 10期
关键词：
D O I：
10.1016/j.jacep.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1314 / 1315
页数：2
相关论文
共 50 条
  • [1] Survival after primary prevention implantable cardioverter-defibrillator implantation in the elderly
    Fauchier, L.
    Marijon, E.
    Defaye, P.
    Sadoul, N.
    Gras, D.
    Klug, D.
    Piot, O.
    Deharo, J. C.
    Leclercq, C. H.
    Boveda, S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 768 - 768
  • [2] Update on primary prevention implantable cardioverter-defibrillator therapy
    Epstein A.E.
    Current Cardiology Reports, 2009, 11 (5) : 335 - 342
  • [3] Age Differences in Primary Prevention Implantable Cardioverter-Defibrillator Use in US Individuals
    Tsai, Vivian
    Goldstein, Mary K.
    Hsia, Henry H.
    Wang, Yongfei
    Curtis, Jeptha
    Heidenreich, Paul A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (09) : 1589 - 1595
  • [4] Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction
    Baman, Jayson R.
    Patil, Kaustubha D.
    Medhekar, Ankit N.
    Wilcox, Jane E.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 585 - 596
  • [5] USE OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    HARGROVE, WC
    MILLER, JM
    JOSEPHSON, ME
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (01): : 63 - 64
  • [6] Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation
    Ptaszek, LM
    Wang, PJ
    Hunt, SA
    Valantine, H
    Perlroth, M
    Al-Ahmad, A
    HEART RHYTHM, 2005, 2 (09) : 931 - 933
  • [7] Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
    Reinder Evertz
    Tessa van der Heijden
    Rypko Beukema
    Sjoerd Westra
    Esther Meindersma
    Caroline van Deursen
    Kevin Vernooy
    Netherlands Heart Journal, 2023, 31 : 348 - 356
  • [8] Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes
    Pick, Justin M.
    Batra, Anjan S.
    CARDIOLOGY IN THE YOUNG, 2017, 27 : S126 - S131
  • [9] Programming implantable cardioverter-defibrillator in primary prevention: Guideline concordance and outcomes
    Ananwattanasuk, Teetouch
    Tanawuttiwat, Tanyanan
    Chokesuwattanaskul, Ronpichai
    Lathkar-Pradhan, Sangeeta
    Barham, Waseem
    Oral, Hakan
    Thakur, Ranjan K.
    Jongnarangsin, Krit
    HEART RHYTHM, 2020, 17 (07) : 1101 - 1106
  • [10] Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
    Evertz, Reinder
    van der Heijden, Tessa
    Beukema, Rypko
    Westra, Sjoerd
    Meindersma, Esther
    van Deursen, Caroline
    Vernooy, Kevin
    NETHERLANDS HEART JOURNAL, 2023, 31 (09) : 348 - 356
12345